Clinical Trials

Showing trials with last updates posted in 2025.

NCT06077968 | ACTIVE_NOT_RECRUITING
1 Participants

A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

Study Type: OBSERVATIONAL
Last Updated: 2025-12-18
Start Date: 2023-11-01
Completion: 2029-05-01
Conditions
Respiratory Syncytial Viruses
Interventions
BIOLOGICAL
No Results Yet
NCT06072924 | RECRUITING | NA
70 Participants

K01 Impacts of Lingual Endurance Exercise

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-01
Completion: 2027-08-31
Conditions
Dysphagia Dysphagia, Oropharyngeal Ischemic Stroke Stroke
Interventions
BEHAVIORAL
No Results Yet
NCT06070116 | ACTIVE_NOT_RECRUITING | PHASE2
300 Participants

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-04-05
Completion: 2026-09-01
Conditions
Onchocercal Subcutaneous Nodule Onchocerciasis Onchocerciasis, Ocular Onchocerca Infection Tropical Disease
Interventions
DRUG
No Results Yet
NCT06068530 | RECRUITING | PHASE4
10000 Participants

Mass Vaccine and Drug Administration, Bangladesh

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2025-02-15
Completion: 2028-02-01
Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT06063317 | ACTIVE_NOT_RECRUITING | PHASE1
50 Participants

A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-10-02
Completion: 2027-06-30
Conditions
Solid Tumor, Adult
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06055985 | COMPLETED | PHASE2
207 Participants

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-11-17
Completion: 2025-03-31
Conditions
Parkinson Disease
Interventions
OTHER DRUG
No Results Yet
NCT06053450 | COMPLETED | NA
20 Participants

The Effect of Essential Oil Inhalation Patches on Perceived Burn-out & Stress on an Inpatient Medical-surgery Unit.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2025-06-30
Completion: 2025-11-20
Conditions
Nursing Personnel
Interventions
OTHER
No Results Yet
NCT06049225 | COMPLETED | NA
90 Participants

Medical Nutrition Therapy and Diabetes Self-Management Education for People With Disabilities

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-06-01
Completion: 2025-07-31
Conditions
Type 2 Diabetes Physical Disability
Interventions
BEHAVIORAL
No Results Yet
NCT06047080 | ACTIVE_NOT_RECRUITING | PHASE3
1130 Participants

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-18
Completion: 2027-12-31
Conditions
Large B-Cell Lymphoma
Interventions
DRUG
No Results Yet
NCT06044740 | RECRUITING | EARLY_PHASE1
60 Participants

Sevoflurane's Effect on Neurocognition Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-01-17
Completion: 2026-03-01
Conditions
Anesthesia Pain Amnesia
Interventions
DRUG DEVICE
No Results Yet
NCT06040086 | ACTIVE_NOT_RECRUITING | PHASE3
1454 Participants

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-22
Completion: 2026-03-02
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG
No Results Yet
NCT06036836 | ACTIVE_NOT_RECRUITING | PHASE2
160 Participants

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-29
Completion: 2026-03-31
Conditions
Solid Tumor Cutaneous Squamous Cell Carcinoma Endometrial Cancer
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06033391 | COMPLETED | NA
94 Participants

Mobile App for Obsessive-compulsive Disorder in Adolescents

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-04-09
Completion: 2024-05-24
Conditions
Obsessive-Compulsive Disorder in Adolescence
Interventions
DEVICE
No Results Yet
NCT06030063 | RECRUITING
5000 Participants

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Study Type: OBSERVATIONAL
Last Updated: 2025-12-18
Start Date: 2024-02-22
Completion: 2026-12-31
Conditions
General Anesthesia Cesarean Delivery
No Results Yet
NCT06029595 | TERMINATED | PHASE2
517 Participants

Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-11-26
Completion: 2025-12-09
Conditions
Uncontrolled Asthma
Interventions
DRUG
No Results Yet
NCT06027814 | ACTIVE_NOT_RECRUITING | NA
40 Participants

MHealth Incentivized Adherence Plus Patient Navigation

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-01-03
Completion: 2025-04-14
Conditions
Opioid Use Disorder Medication Adherence Polysubstance Drug Use (Indiscriminate Drug Use) Methamphetamine-dependence
Interventions
BEHAVIORAL
No Results Yet
NCT06015750 | WITHDRAWN | PHASE4
0 Participants

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2026-07-29
Completion: 2030-03-13
Conditions
Hypophosphatasia
Interventions
DRUG
No Results Yet
NCT06005220 | COMPLETED | NA
143 Participants

SBD121, a Synbiotic Medical Food for RA Management

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-30
Completion: 2025-10-06
Conditions
Rheumatoid Arthritis
Interventions
OTHER
No Results Yet
NCT06001177 | COMPLETED | PHASE2
55 Participants

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-12-13
Completion: 2025-01-03
Conditions
Celiac Disease Coeliac Disease
Interventions
DRUG
NCT05998278 | RECRUITING | NA
330 Participants

Personalized Optimization of Systematic Prostate Biopsy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-08-23
Completion: 2025-12-30
Conditions
Prostate Adenocarcinoma
Interventions
PROCEDURE
No Results Yet
NCT05989230 | RECRUITING | NA
30 Participants

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-08-28
Completion: 2027-08-01
Conditions
Orthopaedic Trauma Chronic Pain Musculoskeletal Injury
Interventions
BEHAVIORAL
No Results Yet
NCT05983250 | RECRUITING | PHASE3
230 Participants

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-01-10
Completion: 2026-10-31
Conditions
Pulmonary Hypertension
Interventions
DRUG
No Results Yet
NCT05974644 | NOT_YET_RECRUITING
1000 Participants

Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

Study Type: OBSERVATIONAL
Last Updated: 2025-12-18
Start Date: 2026-02-28
Completion: 2030-12-01
Conditions
Amyloidosis, Hereditary
Interventions
OTHER
No Results Yet
NCT05964205 | ACTIVE_NOT_RECRUITING
9704 Participants

Analysis of a Stepped-Wedge Implementation of the PT-PENCIL Tool

Study Type: OBSERVATIONAL
Last Updated: 2025-12-18
Start Date: 2023-07-18
Completion: 2024-06-01
Conditions
Physical Therapy Evaluation
Interventions
OTHER
No Results Yet
NCT05959655 | COMPLETED | NA
38 Participants

Modern Urodynamics System Efficacy (MUSE) Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-08-21
Completion: 2024-04-18
Conditions
Urologic Diseases Urodynamics
Interventions
DEVICE
NCT05958342 | RECRUITING | PHASE2
1050 Participants

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-06-30
Completion: 2027-03-31
Conditions
Trauma Hemorrhage
Interventions
DRUG
No Results Yet
NCT05957978 | COMPLETED | PHASE2
52 Participants

LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-03-29
Completion: 2025-06-27
Conditions
Primary Visceral Leishmaniasis
Interventions
DRUG
No Results Yet
NCT05943444 | RECRUITING | NA
256 Participants

Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-08-08
Completion: 2027-08-08
Conditions
Rectal Neoplasms Low Anterior Resection Syndrome Anastomotic Leak Quality of Life
Interventions
PROCEDURE
No Results Yet
NCT05940350 | RECRUITING | NA
60 Participants

Telerehabilitation-Based Coaching Interventions (TeleSCoP) for Patients With Ischemic Stroke

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2025-02-01
Completion: 2025-12-31
Conditions
Ischemic Stroke Coaching
Interventions
BEHAVIORAL
No Results Yet
NCT05926960 | ACTIVE_NOT_RECRUITING | PHASE2
38 Participants

A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-06-13
Completion: 2026-01-19
Conditions
Melanoma
Interventions
DRUG
No Results Yet
NCT05906446 | COMPLETED | NA
50 Participants

Post-acute Multicomponent Frailty Intervention

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-06-15
Completion: 2024-10-31
Conditions
Frailty
Interventions
OTHER
No Results Yet
NCT05902533 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
33 Participants

REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-08-14
Completion: 2026-08-14
Conditions
Anal Cancer
Interventions
RADIATION DRUG
No Results Yet
NCT05894005 | RECRUITING | NA
44 Participants

The Use of Immersive 360-degree Video in Improving Spatial Orientation

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2025-11-08
Completion: 2026-07-31
Conditions
Virtual Reality
Interventions
OTHER
No Results Yet
NCT05884476 | RECRUITING | NA
180 Participants

Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2024-01-08
Completion: 2027-06-30
Conditions
Suicidal Ideation Suicide, Attempted
Interventions
OTHER BEHAVIORAL
No Results Yet
NCT05883748 | ENROLLING_BY_INVITATION | PHASE2/PHASE3
230 Participants

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-08-31
Completion: 2028-06-30
Conditions
Erythropoietic Protoporphyria
Interventions
DRUG
No Results Yet
NCT05875740 | COMPLETED
16 Participants

Correlation of Memory CD8+ T Cells With Sepsis Severity and Mortality: a Single-center, Unblinded, Prospective, Non-interventional, Observational Study

Study Type: OBSERVATIONAL
Last Updated: 2025-12-18
Start Date: 2023-09-06
Completion: 2024-11-03
Conditions
Sepsis Inflammatory Response
No Results Yet
NCT05874037 | COMPLETED | PHASE2/PHASE3
191 Participants

Fluvoxamine for Long COVID-19

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-05-15
Completion: 2025-03-15
Conditions
Long COVID
Interventions
DRUG
No Results Yet
NCT05871125 | COMPLETED | NA
33 Participants

Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-07-01
Completion: 2025-12-01
Conditions
Breast Cancer
Interventions
BEHAVIORAL
No Results Yet
NCT05860296 | TERMINATED | PHASE1/PHASE2
36 Participants

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-05-31
Completion: 2025-12-01
Conditions
Lung Cancer, Nonsmall Cell Lung Cancer Stage IV Lung Cancer Metastatic
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT05854667 | RECRUITING | PHASE2
440 Participants

Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

Study Type: INTERVENTIONAL
Last Updated: 2025-12-18
Start Date: 2023-12-05
Completion: 2027-12-31
Conditions
Methamphetamine Abuse Methamphetamine-dependence Addiction, Substance Addiction
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page